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a Functional C-Domain Dimerization InterfaceRebeca Bocanegra,† Carlos Alfonso,‡ Alicia Rodrı´guez-Huete,† Miguel A´ngel Fuertes,† Mercedes Jime´nez,‡
Germa´n Rivas,‡ and Mauricio G. Mateu†*
†Centro de Biologı´a Molecular ‘‘Severo Ochoa’’ (Consejo Superior de Investigaciones Cientı´ficas-Universidad Auto´noma de Madrid) and
‡Centro de Investigaciones Biolo´gicas (Consejo Superior de Investigaciones Cientı´ficas), Madrid, SpainABSTRACT Polymerization of the intact capsid protein (CA) of HIV-1 into mature capsidlike particles at physiological ionic
strength in vitro requires macromolecularly crowded conditions that approach those inside the virion, where the mature capsid
is assembled in vivo. The capsid is organized as a hexameric lattice. CA subunits in each hexamer are connected through inter-
faces that involve the CA N-terminal domain (NTD); pairs of CA subunits belonging to different hexamers are connected through
a different interface that involves the C-terminal domain (CTD). At physiological ionic strength in noncrowded conditions, CA
subunits homodimerize through this CTD-CTD interface, but do not hexamerize through the other interfaces (those involving
the NTD). Here we have investigated whether macromolecular crowding conditions are able to promote hexamerization of
the isolated NTD and/or full-length CA (with an inactive CTD-CTD interface to prevent polymerization). The oligomerization state
of the proteins was determined using analytical ultracentrifugation in the absence or presence of high concentrations of an inert
macromolecular crowding agent. Under the same conditions that promoted efficient assembly of intact CA dimers, neither NTD
nor CA with an inactive CTD-CTD interface showed any tendency to form hexamers or any other oligomer. This inability to
hexamerize was observed even in macromolecularly crowded conditions. The results indicate that a functional CTD-CTD
interface is strictly required for hexamerization of HIV-1 CA through the other interfaces. Together with previous results, these
observations suggest that establishment of NTD-CTD interactions involved in CA hexamerization during mature HIV-1 capsid
assembly requires a homodimerization-dependent conformational switching of CTD.INTRODUCTIONThe mature capsid of the human immunodeficiency virus
(HIV-1) is assembled within the newly formed virion from
capsid protein (CA) subunits released by proteolytic process-
ing of the Gag precursor polyprotein (1–4). CA contains two
independent domains: the N-terminal domain (NTD) and the
C-terminal domain (CTD). The basic structural organization
of both authentic mature capsids of HIV-1 and mature cap-
sidlike particles assembled in vitro is the same, and consist
of a lattice of CA hexamers (5,6). The NTDs connect
neighbor subunits in each hexamer through two discrete
interfaces (the NTD-NTD and NTD-CTD interfaces). The
CTDs connect pairs of subunits belonging to different hex-
amers through a third, different interface (the CTD-CTD
homodimerization interface) (1,2,7) (see Fig. 1). A fourth,
very small interface has been identified between CTDs
around each threefold symmetry axis in the lattice (8).
Research on the molecular structure, conformational
dynamics, and energetics of CA and CA-CA interfaces
is contributing to a detailed structural understanding of
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0006-3495/13/02/0884/10 $2.00the design of antiviral agents able to inhibit either process
(recently reviewed in Prevelige (9), Waheed and Freed
(10), and Bocanegra et al. (11)). Soluble dimers of intact
CA from HIV-1 are obtained under nonpolymerizing condi-
tions and constitute the stable building blocks from which
the capsid is assembled (1–4). The CTD-CTD interface is
structurally and energetically preserved in both soluble
CA and the isolated CTD dimer, which allowed its descrip-
tion in atomic detail (8,12–15), and its thermodynamic
dissection at the single-residue level (16). From that knowl-
edge, peptides able to inhibit HIV-1 capsid assembly
in vitro, and virus infectivity ex vivo, have been rationally
designed (11,17,18).
In contrast to CA dimerization, the thermodynamics of
CA hexamerization has not been investigated, as soluble
hexamers of the HIV-1 NTD or full-length CA (with
a nonfunctional CTD-CTD interface to prevent polymeriza-
tion) could not be obtained (19,20). Recently, CA of HIV-1
was engineered to form soluble hexamers by crosslinking
the monomers through nonnatural disulfide bridges intro-
duced at the NTD-NTD interfaces. Dimerization of hexam-
ers and capsid assembly were prevented by inactivating the
CTD-CTD interface through a double mutation (W184A/
M185A). The atomic structure of this modified CA hexamer
and the NTD-NTD and NTD-CTD interfaces in it have been
described in atomic detail (21–23). However, the presence of
the covalent disulfide bonds in the modified hexamer mayhttp://dx.doi.org/10.1016/j.bpj.2012.12.035
FIGURE 1 Schematic models of CA oligomers
obtained by x-ray crystallography and formation
of the capsid hexameric lattice. (Cylinders)
Helices. (Green) NTD; (red) CTD. (a) CA hex-
amer. Each NTD-NTD interface is defined by
helices 1 and 3 of one monomer and helix 2 of
the neighboring monomer (21). (b) Side-view of
two neighboring subunits in the CA hexamer. The
NTD-CTD interface is defined by parts of helices
4 and 7 of NTD belonging to one monomer and
helices 8 and 11 of CTD belonging to the other
monomer. (c) CTD dimer. The CTD-CTD interface
is defined mainly by helix 9 of each monomer (14).
The models were produced using the program
PyMol (51). (d) A scheme of the formation of the
capsid hexameric lattice from stable CA dimers.
Each CA monomer is represented by two contig-
uous circles (green, NTD; and red, CTD). Interac-
tions (interfaces) between CA domains, either from
the same monomer or from different monomers are
represented by (blue bars). (Top left) Soluble CA
dimers with monomers joined through the CTD-
CTD interface constitute the stable building blocks
from which the capsid is assembled. (Bottom right)
Establishment of NTD-NTD and NTD-CTD
interactions between different CA dimers leads to
formation of the hexameric rings and, thus, of the
entire capsid lattice. Different pathways for the
formation of each hexamer are possible, including: (i) a sixth-order reaction in which all six subunits in each ring simultaneously click into place; or (ii)
a series of second-order reactions in which subunits are successively joined, until each hexameric ring is closed. The conclusions of this study are independent
of which hexamerization pathway actually occurs. (e) A scheme of the predicted formation of independent hexamers from stable CAW184A/W185A monomers.
(Top left) Soluble CAW184A/W185A monomers cannot dimerize because they carry mutations in the CTD-CTD interface. (Bottom right) If structuration of the
NTD-NTD and NTD-CTD interacting surfaces does not depend on CA dimerization through the separate CTD-CTD interface, independent hexamers could
still be formed. The results of this study show that no such hexamers are formed from CA monomers, even under macromolecular crowding conditions that
increase CA activity and efficiently promote the formation of the hexameric lattice from CA dimers as in panel d.
Molecular Crowding and HIV-1 Capsid Assembly 885prevent a thermodynamic dissection of these interfaces. Like
the disulfide-modified CA of HIV-1, NTD of CA from the
related murine leukemia virus was able to hexamerize, albeit
only in molecular crystals formed from highly concentrated
solutions under nonphysiological conditions (24).
These observations reveal that in these far-from-physio-
logical conditions, the presence of an active CTD-CTD
interface or of the CTD itself are not strictly required for
CA hexamerization. If the same were true when no disul-
fides are introduced, the absence of hexamerization of
both NTD and CA (with an inactive dimerization interface)
of HIV-1 could be explained by a simple, but untested possi-
bility: the NTD-NTD and NTD-CTD interactions could be
of such a low affinity that hexamerization would require
a very high CA effective concentration, such as that found
in the HIV-1 virion. This high effective concentration may
have been reached in laboratory conditions by condensation
of NTD molecules during crystal growth or through the
formation of the disulfides in CA, but not in other in vitro
experiments using closer to physiological conditions.
Two reasons account for the very high CA effective
concentration in the HIV-1 virion:
1. The CA nominal concentration in a typical virion may be
~4 mM (6,25).2. The HIV-1 virion contains many copies of different viral
and cellular proteins and two viral RNA molecules, and
the total macromolecular concentration is ~300 mg/mL
(see Table S1 in the Supporting Material).
Thus, the interior of the HIV-1 virion is a macromolecularly
crowded environment.
Macromolecular crowding is widespread in cells and
biological fluids. The total concentration of macromolecules
in them is extremely high (~50–400 mg/mL), and a large
fraction of the total volume (in a cell, ~20–40%) is occupied
by the macromolecular solutes, leading to significant
volume exclusion effects. This condition can produce large
quantitative effects in the kinetics and thermodynamics of
biochemical reactions involving molecular interactions
within or between macromolecules, such as protein folding
or oligomerization (26–28). Crowding increases up to
several orders of magnitude the chemical activity (effective
concentration) of macromolecules, favoring the association
equilibria between macromolecules that have any intrinsic
tendency to interact with each other. This effect arises
because the reduction in the volume occupied by the macro-
molecules in its associated state, relative to its dissociated
state, reduces the total excluded volume, which decreases
the free energy of the system (26,27). The calculationsBiophysical Journal 104(4) 884–893
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crowded as a cell, with perhaps ~30% of its internal volume
occupied by macromolecules. Thus, similar crowding-
related effects may occur in cells and in the HIV-1 virion.
The effects of macromolecular crowding in a variety of
biochemical reactions and processes involving cellular
proteins have been previously investigated (28). However,
the influence of the physiologically crowded environment
in molecular recognition events involved in viral infec-
tion are essentially unexplored. The scarce experimental
evidence so far indicates, in agreement with theoretical
predictions, that macromolecular crowding may be a critical
driving force for virus morphogenesis (29), and reduces the
inhibitory activity of small antiviral agents targeting
protein-protein interactions (30).
In previous HIV-1 capsid assembly experiments in vitro,
CA concentrations used were well below 1 mM (typically,
a few tens of mM). Under such conditions, CA was com-
pletely unable to polymerize into mature capsidlike parti-
cles, unless special conditions were used:
1. A fusion CA-NC protein in the presence of nucleic acid
(31–33); or
2. A very high ionic strength (>1–2 M NaCl) (19).
The added nucleic acid may act as a CA-NC condensing
agent by binding to NC; a high ionic strength may screen
the electrostatic repulsions and steric effects that occur
between CA subunits (16,34,35). In either case, CA
assembly does occur, but under nonphysiological condi-
tions. However, we showed that highly efficient assembly
of the mature HIV-1 capsid can be achieved in vitro in the
absence of NC and nucleic acid and at physiological ionic
strength, by simply adding a high concentration (100–
200 mg/mL) of an inert macromolecular crowding agent,
to bring the chemical activity of CA closer to that found
inside the virion (29). Furthermore, if the reaction is carried
out at very high ionic strength, addition of the crowding
agent allows the rapid and efficient assembly of CA at
much lower protein concentrations than those required if
no crowder is added.
In this study, we have analyzed whether hexamerization
of NTD and/or the full-length CA (with an inactive CTD-
CTD interface) could be likewise promoted by raising,
through addition of a molecular crowding agent, the CA
chemical activity. Even under exactly the same conditions
that promoted efficient assembly of intact CA into capsid-
like particles, and using much higher protein concentrations
in crowded conditions, neither NTD nor CAwith an inactive
CTD-CTD interface showed any significant tendency to
form any kind of oligomer. The results indicate that hexame-
rization of native CA of HIV-1 requires a functional
CTD dimerization interface, and suggest that establishment
of NTD-CTD interactions during mature HIV-1 capsid
assembly requires a dimerization-dependent conformational
rearrangement in CTD.Biophysical Journal 104(4) 884–893MATERIALS AND METHODS
Protein expression and purification
The isolated NTD and full-length CA, either intact or with an inactivated
CTD-CTD interface through mutations W184A/M185A (CAW184A/M185A),
were expressed from plasmids pET21b(þ)-NTD, pWISBH10 (34), and
pWISBH10-W184A/M185A (a mutagenized plasmid derived from
pWISBH10). The DNA segment coding for NTD (CA residues 1–145)
from HIV-1 strain BH10 was amplified from plasmid pDAB72 by the
PCR method. pDAB72 was obtained through the AIDS Research and
Reference Reagent Program, Division of AIDS, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Bethesda,
MD, from Dr. S. Erickson-Viitanen (Erickson-Viitanen et al. (36)). The
oligonucleotides used were designed to engineer NdeI and BamHI sites
as well as initiation and termination codons immediately flanking the CA
sequence. The amplified DNA was cloned in a recombinant plasmid
pET21b(þ). The isolated NTD, CA, and CAW184A/M185A were purified
essentially as previously described for intact CA (16). Protein stocks
were run in sodium-dodecyl-sulfate polyacrylamide gel electrophoresis
gels and found to be essentially pure. Protein concentration was determined
as described in Gill and von Hippel (37).Kinetic analysis of CA polymerization
Assembly reactions were carried out essentially as described previously in
del Alamo et al. (29) and Rinco´n et al. (30). Briefly, the polymerization
mixtures contained 50 mM sodium phosphate buffer pH 7.4, 2.25 M
NaCl, and 46 mMCA, or 20 mM and 100 mg/mL Ficoll-70 (GE HealthCare,
Little Chalfont, UK) as a macromolecular crowding agent. The experiments
were initiated by introducing an appropriate volume of a CA solution in
50mM phosphate buffer into a spectrophotometer cuvette, and the assembly
reaction was triggered by adding the appropriate volume of a solution con-
taining 4 M NaCl and, when indicated, 179 mg/mL Ficoll-70 in 50 mM
sodium-phosphate buffer pH 7.4 to get the final concentrations desired for
each component in a final volume of 500 mL, followed by rapid mixing by
repeated inversion of the cell. The pH of the final reaction mixture was
checked in a test sample. The time-dependent increase in the optical density
at 350 nm as a measure of the light scattered by the assembled particles was
monitored at 25C using a UV-1603 spectrophotometer (Shimadzu, Kyoto,
Japan), with data points collected every 6 s. Traces of the variation in the
turbidity were analyzed as described previously in del Alamo et al. (29)
and Rinco´n et al. (30) using an empirical Hill function,
OD ¼ ODf
 ðt=t50Þn
ð1þ ðt=t50ÞnÞ

; (1)
where OD is the optical density at incubation time t; ODf is the optical
density at infinite time; t50 is the time at which the OD is equal to one-
half the ODf; and n is a Hill coefficient/cooperativity parameter.Analytical ultracentrifugation
Sedimentation analysis of NTD and CAW184A/M185A was performed at
several protein concentrations (from 33 mM to 1 mM monomer). All
samples were in 50 mM sodium-phosphate buffer pH 7.4, 2.25 M NaCl,
in the absence or presence of Ficoll-70 (at 100 mg/mL unless stated other-
wise). Sedimentation velocity experiments were carried out at 48,000 rpm
and 20C in a XL-A analytical ultracentrifuge (Beckman Coulter, Brea,
CA) with a UV-Vis optics detection system, using an An50Ti rotor and
12-mm double-sector centerpieces except where indicated otherwise.
Sedimentation profiles were registered every 3 min at 250 nm (NTD) or
300 nm (CAW184A/M185A). The sedimentation coefficient distributions
were calculated by least-squares boundary modeling of sedimentation
Molecular Crowding and HIV-1 Capsid Assembly 887velocity data using the c(s) method (38,39) as implemented in the software
SEDFIT (National Institutes of Health, Bethesda, MD). These s values were
corrected to standard conditions (water, 20C, and infinite dilution)
using the software SEDNTERP (Biomolecular Interaction Technologies
Center, University of New Hampshire, http://bitcwiki.sr.unh.edu/index.
php/Main_Page), yielding the corresponding standard s values (s20,w).
Low-speed (18,000 and 20,000 rpm) sedimentation equilibrium experi-
ments were performed to determine the size and self-association properties
of NTD as a function of protein concentration, using short columns (80 mL)
and the same experimental protocol described above. After the equilibrium
scans, a high-speed centrifugation run (48,000 rpm) was conducted to
estimate the corresponding baseline offsets.
For each solution composition, the whole-cell apparent weight-average
buoyant molecular weight (M*i,app) of either NTD or CAW184A/M185A was
determined by fitting Eq. 2 to the experimentally measured equilibrium
gradient,
SiðrÞ ¼ Siðr0Þ exp

Mi;app
2RT

r2  r20

; (2)
where Si (r) is the magnitude of a signal proportional to the weight/volume
concentration of NTD or CAW184A/M185A at radial position r (i.e., absor-
bance at 280 nm); r0 is an arbitrarily selected reference position; R is the
molar gas constant; and T the temperature.
Under conditions of thermodynamic ideality (high dilution of all macro-
molecular species), the apparent buoyant massM*i,app is equal to the actual
buoyant mass Mi. The average molecular weights (M*i ) of the different
proteins were obtained from the corresponding buoyant values with
M*i ¼ Midi, where di denotes the specific density increments of Ficoll,
NTD, or CAW184A/M185A. The analysis was done using the EQASSOC
(40) and HETEROANALYSIS (41) programs, which yielded the same
results within 5% experimental error.
The SE approach applied in this study, using short solution columns and
low rotor speeds to yield shallow gradients, simplifies the analysis and inter-
pretation of the results obtained. Under these conditions, M*i,app becomes
independent of radial distance, and is well described by the solution-
average molecular weight value, which may be expressed as a function
of the loading protein concentration and analyzed assuming given self-
association schemes as described elsewhere in the literature (42–44).
Tracer sedimentation equilibrium
Experiments to characterize the effect of Ficoll-70 concentration on the
state of association of NTD and CAW184A/M185Awere performed essentially
as described in Darawshe et al. (45). Sample solution was prepared in
50 mM sodium phosphate buffer pH 7.4, 2.25 M NaCl using a broad range
of Ficoll-70 concentrations (up to 100 g/L) in the absence and in the pres-
ence of a fixed concentration of NTD or CAW184A/M185A. Solution samples
(70 mL total volume) were loaded over 90 mL of fluorocarbon and then
overlaid by an equal amount of mineral oil. Samples were centrifuged to
sedimentation equilibrium at 20,000 rpm and 20C in an Optima MAX
XL preparative ultracentrifuge (Beckman-Coulter) using small polycarbon-
ate tubes and a TLD-55 rotor, as described previously in Darawshe et al.
(45). After sedimentation equilibrium was attained (elapsed time > 48 h),
gradients were obtained via fractionation of tube contents with a FR-115
centrifuge tube microfractionator (Brandel, Gaithersburg, MD) (45). The
concentration of protein in each fraction was determined by measuring their
absorbance at 280 nm, and the concentration of Ficoll was measured by
refractometry. The apparent signal-average buoyant molecular weight of
Ficoll or NTD/CAW184A/M185A in each solution was determined by fitting
Eq. 2 to the experimental gradients as described above.
Nonideal tracer sedimentation equilibrium analysis
The general expression that describes the condition of sedimentation equi-
librium in a solution containing an arbitrary number of solute species atarbitrary concentrations states that the apparent buoyant mass of a given
molecular species depends upon its interactions with all the species of
the solution mixture (43)
Mi;app ¼ Mi 
X
j
wj

dlngi
dwj

Mj;app; (3)
where wj denotes the w/v concentration of species j, and gi is the activity
coefficient of species i. The quantity (d ln gi/dwj) defines the magnitude
of the thermodynamic interactions between species i and j (referred to as
thermodynamic interaction factor (44)). Let us consider that the subscript
1 refers to Ficoll species, while the subscripts 2 and 3 denote NTD or
CAW184A/M185A protein species, respectively. To model the dependence of
M*1,app, M
*
2,app, and M
*
3,app with the concentration of Ficoll, estimating
the value of the thermodynamic interaction factors involved are required.
This was done by using an empirical analysis in which ln gi was expanded
in powers of the concentration of all solute species, as described in Fodeke
and Minton (46),
ln gi ¼
X
j
Bijwj þ
X
j
X
k
Bijkwjwk þ.; (4)
where Bij denotes a coefficient of two-body interactions between molecules
of species i and j, and Bijk is a coefficient evaluating the three-body interac-
tions between molecules of i, j, and k species, etc.
According to this analytical procedure, the dependence of the activity
coefficient of Ficoll with its own concentration is described by
ln g1 ¼ B11w1 þ B111w21 þ. (5)
and the dependence of the apparent buoyant mass of Ficoll with the concen-
tration of Ficoll is described by
M1;app ¼
M1
ð1þ B11w1 þ 2B111w21 þ.Þ
: (6)
Similarly, to analyze the dependence of the apparent buoyant mass of
dilute NTD protein upon Ficoll concentration, Eq. 4 reduces to
ln g2 ¼ B21w1 þ B211w21 þ. (7)
and Eq. 3 reduces to
M2;app ¼ M2 

B21w1 þ 2B211w21 þ.

: (8)
In the case of CAW184A/M185A protein, the formulation described in Eqs. 7
and 8 applies as well if subscript 2 is replaced by subscript 3.
Equations 6 and 8 were used to globally model the dependence of
M*1,app, M
*
2,app, and M
*
3,app upon Ficoll concentration.RESULTS AND DISCUSSION
The isolated NTD of HIV-1 is unable to oligomerize
even in the presence of crowding agents
As a starting point, we evaluated the ability of soluble iso-
lated NTD monomers to form hexamers (or any other kind
of oligomer) in the absence of macromolecular crowding,
under conditions in which soluble full-length CA dimers
are able to polymerize into capsidlike particles.Biophysical Journal 104(4) 884–893
888 Bocanegra et al.In control experiments, CA polymerization kinetics was
followed by turbidimetry (Fig. 2 a) in conditions in which
capsidlike particles with the organization of authentic
HIV-1 capsids are assembled, as shown by electron micros-
copy analysis (29). The results confirmed that full-length
CA does efficiently assemble into capsidlike particles in
50 mM sodium-phosphate buffer pH ¼ 7.4, 2.25 M NaCl,
even at relatively low (30–50 mM and lower) protein (mono-
mer) concentrations (Fig. 2 a). Thus, these conditions do
promote the formation of hexamers of CA dimers (which
is strictly required for the formation of the capsid hexameric
lattice during assembly; see Fig. 1 d). In contrast to full-
length CA, the isolated NTD under those same conditions
(in the absence of crowding) did not show any significant
tendency to form hexamers, or any other oligomer, as deter-
mined by analytical ultracentrifugation in both sedimenta-
tion velocity and sedimentation equilibrium experiments.
In sedimentation velocity experiments using 80-mM
NTD, integration of the experimental data yielded a mono-
disperse peak of protein (Fig. 2 b). The molecular mass Mw
calculated from the sedimentation coefficient s20,w of this
peak corresponded, within experimental error, to the molec-
ular mass of the NTD monomer (16,100 Da). These results
were indistinguishable from those obtained in sedimentation
velocity experiments under the same conditions but at a low
ionic strength (0–150 mM NaCl), conditions in which CA is
unable to polymerize into capsidlike particles and hexame-
rization is not expected.Biophysical Journal 104(4) 884–893In sedimentation equilibrium experiments in 50 mM
sodium-phosphate buffer pH ¼ 7.4, 2.25 M NaCl using
NTD concentrations from 30 mM to 300 mM, analysis of
the experimental data yielded values for the apparent molec-
ular mass Mw,app between ~17,000 and 18,000 Da. Again,
these values corresponded, within experimental error, to
that of the NTD monomer (Fig. 2 c and Table 1). To favor
as much as possible the self-association of the NTD mono-
mer into oligomers, its concentration was increased up to
1 mM (16 mg/mL). Even at this very high concentration,
NTD did not show any significant tendency to oligomerize
(Fig. 2 d and Table 1).
The very high (1-mM) NTD concentration reached in the
above experiments is below the CA concentration inside the
typical maturing HIV-1 virion, and much lower than the CA
effective concentration (chemical activity) in the macromo-
lecularly crowded virion (see the Introduction). If NTD (or
any other protein) has any intrinsic tendency to self-associate
but requires a very high concentration to do so, macromolec-
ular crowding would promote its oligomerization to a certain
extent. If NTD (or any other protein) has no intrinsic
tendency to self-associate, macromolecular crowding would
be totally ineffective in promoting oligomerization. To test
these alternatives, we added Ficoll-70 to the in vitro reaction
mixtures to increase the NTD effective concentration and
bring it closer to that inside the virion. Ficoll-70 (molecular
mass 70,000 Da) is widely used by many researchers as a
chemically defined, inert agent that leads to macromolecularFIGURE 2 Analysis of CA polymerization and
of NTD oligomerization in the absence of Ficoll.
(a) Wild-type CA polymerization kinetics fol-
lowed by turbidimetry. CA concentrations of 30
mM (squares), 40 mM (circles), and 50 mM (trian-
gles) in 50 mM phosphate buffer, pH 7.4, 2.25 M
NaCl were used. (b) Analysis of NTD oligomeriza-
tion by sedimentation velocity using 80-mM
protein in 50-mM phosphate buffer, pH 7.4, 1 M
NaCl. The plot represents the protein concentra-
tion, c(s), as a function of the sedimentation coef-
ficient, s20,w, as obtained from integration of
sedimentation velocity curves. A monodisperse
peak with a sedimentation coefficient correspond-
ing to that of monomeric NTD is observed.
(c and d) Analysis of NTD oligomerization by
sedimentation equilibrium. The plots represents
the absorbance at 295 nm with a 12-mm center-
piece (c) or 298 nm with a 3-mm centerpiece
because the signal was too high to use the regular
centerpiece (d) as a function of the centrifugation
radius, using NTD concentrations of 100 mM (c)
or 1 mM (d) and a centrifugation velocity of
20,000 rpm in the same buffer used in panel a.
Analysis of the concentration gradients was per-
formed with the program HETEROANALYSIS
(41), and the resulting apparent molecular masses
(Mapp) obtained for NTD are shown in Table 1.
TABLE 1 Apparent molar massMw,app of CA-NTD obtained by
analytical ultracentrifugation in sedimentation equilibrium
experiments in the absence of crowding agent
[NTD] (mM)
Mw,app at 18,000 rpm
(kDa)a
Mw,app at 20,000 rpm
(kDa)a
0.033 17.25 0.4 17.05 0.4
0.10 17.45 0.4 17.25 0.5
0.30 18.05 0.6 17.45 0.5
1.00 18.65 0.7 18.35 0.6
aThe SDs are indicated.
Molecular Crowding and HIV-1 Capsid Assembly 889crowding in simplified in vitro models. However, the use of
200–300 g/L Ficoll to nearly match in the experiments
the total macromolecular concentration in the virion
(~300 mg/mL; see Table S1) would have led to strong devi-
ations from ideality in the analytical ultracentrifugation
experiments and prevented a clear interpretation of data.
Thus, we limited the Ficoll concentration to 100 mg/mL.
This concentration is similar to the total macromolecular
concentration in many physiological environments. Impor-
tantly, 100 mg/mL Ficoll has been shown to strongly pro-
mote macromolecular association in many other systems,
and is enough to increase by several fold the CA effective
concentration. In vitro assembly experiments showed that
100 mg/mL Ficoll strongly promoted polymerization of
full-length CA into capsidlike particles, which under the
conditions of the assay occurred efficiently and rapidly
even at very low protein concentrations (10 mM and lower);
this was determined following the polymerization kinetics
by turbidimetry (Fig. 3 a), and confirmed by electron
microscopy analysis.
The ability of NTD to oligomerize in the presence of
increasing concentrations of Ficoll-70 as a crowding agent,
at a very high NTD concentration (1 mM, corresponding toFIGURE 3 Analysis of CA polymerization and of NTD oligomerization
in the presence of Ficoll. (a) CA polymerization kinetics followed by
turbidimetry. A CA concentration of 10 mM in 50-mM phosphate buffer,
pH 7.4, 2.25 M NaCl, and 100 g/L Ficoll-70 was used. (b) Analysis of
NTD oligomerization in sedimentation equilibrium experiments using
1 mM protein in 50-mM phosphate buffer, pH 7.4, 2.25 M NaCl, and
different concentrations of Ficoll-70. The plot represents the dependence
of the apparent buoyant molar mass (M*app) of NTD upon the concentration
of Ficoll. (Symbols) Experimental data measured by tracer sedimentation
equilibrium as described in Materials and Methods. (Solid line) Best-fit
of the empirical analysis to estimate the dependence of the activity coeffi-
cient of NTD upon solute concentration, as detailed in Materials and
Methods, with the best-fit parameter values indicated in the main text.an effective concentration of up to several mM under these
crowded conditions), was then determined in nonideal sedi-
mentation equilibrium experiments. The dependences of the
apparent buoyant masses of Ficoll and NTD as functions of
Ficoll concentration are, respectively, shown in Fig. S1 in
the Supporting Material and in Fig. 3 b. In both cases, the
buoyant mass values decrease with increasing concentration
of Ficoll, indicating that interactions are predominantly
repulsive. The combined data were quantitatively described
by an empirical expansion of the logarithm of the activity
coefficient of each species in powers of the concentration
of the crowder species (see Materials and Methods),
truncated after the quadratic terms.
This treatment requires specifying the buoyant masses of
the species present and the corresponding two- and three-
body interaction coefficients; it assumes as well that interac-
tions between species are essentially due to excluded
volume, and that single species of tracer protein and crow-
der are present in the solution mixture. This does not have
to be necessarily the case, but it turned out that this simpli-
fying assumption accounted quantitatively for the data.
Application of Eqs. 6 and 8 to the data rendered the
following best-fit parameter values (subscripts 1 and 2 refer
to Ficoll and NTD, respectively): M*1 ¼ 23,200 5 1500;
M*2 ¼ 4400 5 600; B11 ¼ 30 5 8 mL/g; B111 ¼ 240 5
40 (mL/g)2; B21 ¼ 7 5 3 mL/g; and B211 ¼ 55 5 25
(mL/g)2. The buoyant molar masses are in agreement with
the values expected for the monomeric species (25,000
and 4600, respectively).
The dependence of the activity coefficient of each species
with the concentration of Ficoll, calculated from the best-fit
M*i values and the corresponding Bij and Bijk coefficients
using Eqs. 5 and 7, revealed that the Ficoll-Ficoll interac-
tions are more repulsive (in very good agreement with
previous data; see Fodeke and Minton (46)), than the inter-
actions of capsid proteins and Ficoll; this finding was ex-
pected from excluded volume effects, because Ficoll has
a larger volume of exclusion per mass than the capsid pro-
teins. Therefore, the sedimentation equilibrium data can
be described without the need to propose additional associ-
ations, indicating a lack of significant self-associations or
hetero-associations of either component. These results re-
vealed that the isolated NTD has no intrinsic tendency to
form any kind of oligomer, even under macromolecular
crowding conditions.The full-length CA of HIV-1 with an inactive
dimerization interface is unable to oligomerize
even in the presence of crowding agents
One possibility to interpret the intrinsic inability of the iso-
lated NTD from HIV-1 to hexamerize is that the association
energy contributed by the NTD-CTD interfaces is strictly
required for CA hexamerization (contrary to the case of
CA from murine leukemia virus in which the NTD aloneBiophysical Journal 104(4) 884–893
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tions). In such a case, it should be still possible to obtain
soluble hexamers of full-length CA from HIV-1, provided
that the CA effective concentration is sufficiently high and
CA polymerization is prevented by inactivating the CTD-
CTD dimerization interface. We tested this possibility by
using a mutant full-length CAW184A/W185A containing the
W184A and M185A mutations, which had been previously
shown to drastically impair CTD-CTD dimerization and
HIV-1 capsid assembly (14,16,47,48).
We evaluated first whether the presence of these muta-
tions completely prevented the ability of CA to dimerize
and/or polymerize under the various experimental condi-
tions used in our study. Gel filtration analysis confirmed
that purified CAW184A/W185A at physiologic ionic strength
and in the absence of molecular crowding is in monomeric
form, even at very high protein concentrations (>1 mM)
(data not shown). In addition, polymerization kinetics anal-
ysis followed by turbidimetry showed that CAW184A/W185A
was completely unable to polymerize at all, even under
conditions (very high ionic strength, 2.25 M NaCl; and pres-
ence of a macromolecular crowding agent, 100 mg/mL
Ficoll-70) that allowed a very rapid and efficient polymeri-
zation of nonmutated CA (Fig. 4 a).
Then, we evaluated the ability of CAW184A/W185A to self-
associate into hexamers (or any other kind of oligomer) in
the absence of macromolecular crowding, under the same
conditions in which nonmutated CA is readily able to
polymerize into capsidlike particles (50 mM sodium-
phosphate buffer pH ¼ 7.4, 2.25 M NaCl). Nonmutated
CA did efficiently polymerize at 30–50 mM and lower
protein monomer concentrations (Fig. 2 a); in contrast,
CAW184A/W185A did not show any significant tendency to
oligomerize, as determined by analytical ultracentrifugationFIGURE 4 Analysis of CA polymerization and of full-length CAW184A/M185A o
squares) and mutant CAW184A/M185A (open squares) polymerization kinetics fol
buffer, pH 7.4, 2.25 M NaCl, and 100 g/L Ficoll-70 was used. (b) Analysis of
protein in 50-mM phosphate buffer, pH 7.4, 2.25 M NaCl. The plot represents th
s20,w, as obtained from integration of sedimentation velocity curves. A monodis
meric CAW184A/M185A is observed. (c) Analysis of CAW184A/M185A oligomerizatio
buffer, pH 7.4, 2.25 M NaCl, and different concentrations of Ficoll-70. The plo
CAW184A/M185A upon the concentration of Ficoll. (Symbols) Experimental data m
(Solid line) Best-fit of the empirical analysis to estimate the dependence of the ac
and Methods), with the best-fit parameter values indicated in the main text.
Biophysical Journal 104(4) 884–893in sedimentation velocity experiments, even at higher
(100 mM) protein monomer concentrations. Integration of
the experimental data yielded a monodisperse peak of
protein (Fig. 4 b). The molecular mass Mw calculated
from the sedimentation coefficient s20,w of this peak corre-
sponded, within experimental error, to the molecular mass
of the CA monomer.
As in the equivalent experiments using NTD, the CA
concentration in the above experiments is well below its
concentration in the HIV-1 virion, and even much lower
when compared to the CA effective concentration in the
crowded virion. Again, we used Ficoll-70 as a crowding
agent to get closer to the CA effective concentration inside
the virion, and determine whether full-length CA with an
inactive dimerization interface has any intrinsic tendency
to self-associate. We added up to 100 mg/mL Ficoll-70 to
the reaction mixture. Under these conditions, nonmutated
CA did efficiently polymerize, even at 10 mM and lower
protein monomer concentrations (Fig. 4 a).
The ability of CAW184A/W185A to oligomerize in the
presence of increasing concentrations of Ficoll-70 as a
crowding agent, at a very high CAW184A/W185A concentra-
tion (0.3 mM, corresponding to a severalfold higher effec-
tive concentration under crowded conditions), was then
determined by analytical ultracentrifugation in sedimenta-
tion equilibrium experiments (Fig. 4 c). The data in Fig. 4
c were fitted using the same theoretical model applied for
the NTD case described above. Application of Eqs. 6 and
8 to the data rendered the following best-fit parameter values
(subscripts 1 and 3 refer to Ficoll and CAW184A/W185A,
respectively): M*1 ¼ 23,200 5 1500; M*3 ¼ 6200 5
600; B11 ¼ 30 5 8 mL/g; B111 ¼ 240 5 40 (mL/g)2;
B31 ¼ 2 5 4 mL/g; and B311 ¼ 90 5 30 (mL/g)2. The
buoyant molar masses are in agreement with the valuesligomerization in the absence or presence of Ficoll. (a) Wild-type CA (solid
lowed by turbidimetry. A CA concentration of 20 mM in 50-mM phosphate
CAW184A/M185A oligomerization by sedimentation velocity using 100-mM
e protein concentration, c(s), as a function of the sedimentation coefficient,
perse peak with a sedimentation coefficient corresponding to that of mono-
n by sedimentation equilibrium using 300-mM protein in 50-mM phosphate
t represents the dependence of the apparent buoyant molar mass (M*app) of
easured by tracer sedimentation equilibrium (see Materials and Methods).
tivity coefficient of CAW184A/M185A upon solute concentration (see Materials
FIGURE 5 Structural differences of CTD folded as a free monomer or as
a homodimer subunit, and CTD regions involved in the CTD-CTD and
CTD-NTD interfaces in the mature HIV-1 capsid. (a) Structural models of
the CTD monomer (mutant CAW184A) obtained by NMR (50) (with helices
shown as cylinders) and of a subunit in the CTD dimer (14) (with helices
shown as ribbons) are overlapped. Helix 9 (involved in the CTD-CTD
dimerization interface) is colored (orange) in the subunit of the CTD dimer;
this helix is not permanently structured in the CTD monomer, and the cor-
responding peptide segment appears in the figure as an (orange irregular
ribbon). Helices 10 and 11 (involved in the CTD-NTD dimerization
interface) are colored (blue or green, respectively). (b) Ribbon model of
two contiguous monomers in the crystal structure of the CA hexamer
(21), which are shown in (light and dark gray, respectively). In the (light
gray colored monomer), helices 9-11 are colored as in panel a.
Molecular Crowding and HIV-1 Capsid Assembly 891expected for the monomeric species (25,000 and 6500,
respectively). Again, the sedimentation equilibrium data
can be described without the need to propose additional
associations, indicating a lack of significant self-associa-
tions or hetero-associations of either component. These
results revealed that, like the NTD, CAW184A/W185A has no
intrinsic tendency to form any kind of oligomer, even under
macromolecular crowding conditions.
To summarize, the experiments described show that both
the isolated NTD, and a full-length CA of HIV-1 unable to
homodimerize though the CTD-CTD interface, are unable
to form hexamers (or any other kind of oligomer) through
the NTD-NTD and/or NTD/CTD interfaces, even under
conditions that promote rapid and efficient polymerization
of nonmutated CA into capsidlike particles. This inability
of CA or its NTD ofHIV-1 to form hexamers frommonomers
is still observed under macromolecular crowding conditions
that approach those inside the HIV-1 virion. These obser-
vations indicate that a functional CTD-CTD dimerization
interface and dimerization of CA through its CTD are strictly
required for hexamerization of native CA of HIV-1 through
the other interfaces (NTD-NTD and/or NTD/CTD).
The above results support an allosteric model for
assembly of the mature HIV-1 capsid. This model contem-
plates that CA dimerization through the CTD acts as a
conformational switch for capsid assembly by inducing a
conformational rearrangement in CTD, and creating the
CTD epitope involved in interactions with the NTD of
another CA subunit. This allows the formation of the
NTD-CTD interfaces required for CA hexamerization
and the subsequent assembly of the mature capsid (see
Fig. 1 d). This model is supported, in addition to the results
of this study, by a number of observations:
1. Mutations W184A and M185A at the CTD-CTD dimer-
ization interface are located far away from the NTD-
NTD and NTD-CTD interfaces, and cannot directly
participate in them.
2. Mutations W184A and M185A reduce the association
energy of CTD-CTD dimerization by >10.6 kcal/mol
and 7.6 kcal/mol, respectively (16). Although both single
mutants W184A and M185A are monomeric except
at very high concentrations, the thermodynamic data
show that theW184Amutation has a dominant role in the
inactivation of the CTD-CTD interface in CAW184A/W185.
Biophysical analyses revealed that the stable monomeric
CTDW184A mutant, and the conformationally and ther-
modynamically similar transient monomeric interme-
diate of dimerization of nonmutated CTD, lack a part
of the native tertiary structure present in each subunit
in the CTD dimer (49).
3. In agreement with the later observation, the structure
of monomeric CTD (W184A mutant) at neutral pH
obtained by NMR spectroscopy revealed that the CTD
monomer adopts a somewhat different conformationthan each CTD subunit in the dimer. In particular, the
dimerization helix 9 appears to be only transiently struc-
tured, and helices 10 and 11 have a nearly perpendicular
orientation with respect to their orientation in the CTD
subunit in the dimer ((50); and see Fig. 5 a). Helices
10 and 11 constitute a major part of the CTD epitope
involved in the NTD-CTD dimerization interface in the
mature capsid lattice ((22,23), Fig. 5 b); thus, the CTD
epitope involved in the CTD-NTD interface may not be
formed in the CA monomer. In the disulfide-bridged
CA hexamer, the proximity between the NTD of one
subunit and the CTD of the neighboring subunit strongly
favors NTD-NTD association and greatly increase
the collisions between NTD and CTD, which could
induce-fit the CTD transition, obviating the presence of
an active CTD interface for CA hexamerization.CONCLUSIONS
The results of this study indicate that dimerization of the
HIV-1 capsid protein CA through a functional CTD-CTD
interface is strictly required for the hexamerization of the
dimers through the NTD-NTD and NTD-CTD interfaces
to form the hexameric lattice of the mature virus capsid.
Together with previous observations, this study suggests
that establishment of NTD-CTD interactions involved
in hexamerization of CA during mature HIV-1 capsid
assembly requires a CTD homodimerization-dependent
conformational switching event.SUPPORTING MATERIAL
One table and one figure are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(12)05151-X.Biophysical Journal 104(4) 884–893
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